Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT04093336
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT04093336
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04093336. Randomized; quadruple masking; primary purpose treatment. Start 2019-01-13 (actual); primary completion 2024-12-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients
- Condition
- Infarction, Middle Cerebral Artery
- Condition
- Infarction, Anterior Cerebral Artery
- Condition
- Cerebral Infarction
- Condition
- Stroke, Ischemic
- Condition
- Acute Stroke
- Condition
- Brain Infarction
- Condition
- Infarction, PCA
- Condition
- Infarction, Posterior Circulation, Brain
- Intervention (Biological)
- human umbilical cord mesenchymal stem cells
- Intervention (Biological)
- Placebo
- Intervention (Other)
- standardized treatment
- Lead sponsor
- Shanghai East Hospital
Record details
- Record id
cardio:ct-nct04093336- Content hash
983482e2537aa01cecbb22e5cc889b8d4c89da0be5ad094fbf6cb5c4ac2c0259